HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx-To-OTC Switch Guru Gauld On Importance Of Pharmacist Buy-In, Protocol Finessing

Executive Summary

In the second installment of HBW Insight's exclusive three-part interview, global switch expert Dr Natalie Gauld explains how industry can help pharmacists drive prescription-to-OTC switches in pharmacy. 

You may also be interested in...



Perrigo Pegs Growth To Initiating OTC Switches, Not Following Brands' NDAs

"A foundation of this business has been," says Perrigo's Americas consumer business chief, Jeffrey Needham, "we are a fast follower. That's been our traditional model. We can't afford to do that going forward." In addition to initiating moving ingredients from Rx to OTC, firm is developing "national better brand" versions of drugs already available OTC.

Industry Backs Rx-To-OTC Switch Framework For SE Asia

A European trade group which counts Sanofi, Bayer and GSK among its members is calling for a prescription-to-OTC switch framework to be put in place in south-east Asia to encourage drug reclassifications across the region. 

German Industry Wants To Simplify 'Complicated' Switch Process

The German Medicines Manufacturers´ Association

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel